4.3 Article

Results for local control and functional outcome after linac-based image-guided stereotactic radiosurgery in 190 patients with vestibular schwannoma

Journal

JOURNAL OF RADIATION RESEARCH
Volume 55, Issue 2, Pages 288-292

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jrr/rrt101

Keywords

vestibular schwannoma; acoustic neurinoma; stereotactic radiosurgery; image-guided intervention; local control

Ask authors/readers for more resources

We assessed local control (LC) and functional outcome after linac-based stereotactic radiosurgery (SRS) for vestibular schwannoma (VS). Methods Between 1998 and 2008, 190 patients with VS were treated with SRS. All patients had tumors < 2 cm diameter. Patients received 13.5 Gy prescribed to the 80th isodose at the tumor margin. The primary endpoint was LC. Secondary endpoints were symptomatic control and morbidity. Results Median follow-up was 40 months. LC was achieved in 88% of patients. There were no acute reactions exceeding Grade I. Trigeminal nerve dysfunction was present in 21.6% (n = 41) prior to SRS. After treatment, 85% (n = 155) had no change, 4.4,% (n = 8) had a relief of symptoms, 10.4% (n = 19) had new symptoms. Facial nerve dysfunction was present in some patients prior to treatment, e.g. paresis (12.6%; n = 24) and dysgeusia (0.5%; n = 1). After treatment 1.1% (n = 2) reported improvement and 6.1% (n = 11) experienced new symptoms. Hearing problems before SRS were present in 69.5% of patients (n = 132). After treatment, 62.6% (n = 144) had no change, 10.4% (n = 19) experienced improvement and 26.9% (n = 49) became hearing impaired. Conclusion This series of SRS for small VS provided similar LC rates to microsurgery; thus, it is effective as a non-invasive, image-guided procedure. The functional outcomes observed indicate the safety and effectiveness of linac-based SRS. Patients may now be informed of the clinical equivalence of SRS to microsurgery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

Impact of Adjuvant Ocular Interventions on the Quality of Life of Patients with Uveal Melanoma after Proton Beam Therapy

Johannes Gollrad, Christopher Rabsahl, Antonia M. Joussen, Andrea Stroux, Volker Budach, Dirk Boehmer, Alexander Boeker

Summary: This study investigated the impact of adjuvant local interventions on the quality of life in patients with uveal melanoma after proton therapy. The results showed that these interventions did not have long-lasting effects on the patients' quality of life.

OCULAR ONCOLOGY AND PATHOLOGY (2022)

Article Oncology

Experimental and computational evaluation of capacitive hyperthermia

Marcus Beck, Peter Wust, Eva Oberacker, Alexander Rattunde, Tom Paessler, Benjamin Chrzon, Paraskevi Danai Veltsista, Jacek Nadobny, Ruben Pellicer, Enrico Herz, Lukas Winter, Volker Budach, Sebastian Zschaeck, Pirus Ghadjar

Summary: Objective hyperthermia has been confirmed as an enhancer of radio- and/or chemotherapy through various trials, with positive results from capacitive hyperthermia systems (CHS) observed despite lower specific absorption rates (SAR) in deep regions compared to established techniques. Phantom measurements and simulations for commercial CHS Celsius42 showed effective SAR reaching depths of 6-8 cm in a homogeneous phantom and 10-20 W/kg achieved in intermediate to deep regions despite the presence of a fat layer. The application of CHS is feasible for certain pelvic and abdominal tumor patients, as well as for heating superficial and medium-deep tumors and some bone metastases.

INTERNATIONAL JOURNAL OF HYPERTHERMIA (2022)

Article Oncology

Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis

Felix Ehret, David Kaul, Markus Kufeld, Clara Vom Endt, Volker Budach, Carolin Senger, Christoph Fuerweger, Alfred Haidenberger, Alexander Muacevic

Summary: This study analyzed the outcomes of robotic-assisted short-course stereotactic body radiotherapy (SBRT) for adrenal gland metastases (AGMs). The results showed that short-course SBRT is an effective and safe treatment modality for AGMs, with sporadic and manageable treatment-associated side effects. The study suggests that short-course SBRT can be a preferable and time-saving treatment option for AGMs if an adequate biologically effective dose can be safely applied.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Letter Biochemistry & Molecular Biology

A web-based app to provide personalized recommendations for COVID-19

Alexander H. Thieme, Maximilian Gertler, Mirja Mittermaier, Matthias I. Groeschel, Jonathan H. Chen, Brar Piening, Justus Benzler, Daniel Habenicht, Volker Budach, Olivier Gevaert

NATURE MEDICINE (2022)

Article Oncology

Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy

Shivaprasad Patil, Annett Linge, Marianne Grosser, Fabian Lohaus, Volker Gudziol, Max Kemper, Alexander Nowak, Dominik Haim, Inge Tinhofer, Volker Budach, Maja Guberina, Martin Stuschke, Panagiotis Balermpas, Claus Roedel, Henning Schaefer, Anca-Ligia Grosu, Amir Abdollahi, Juergen Debus, Ute Ganswindt, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, Simon Boeke, Daniel Zips, Gustavo B. Baretton, Michael Baumann, Mechthild Krause, Steffen Loeck

Summary: This study developed and validated a novel prognostic 6-gene signature for predicting loco-regional control of HPV-negative HNSCC patients treated with postoperative radio(chemo)therapy. The signature showed predictive significance in both training and validation cohorts, and could improve personalized clinical trials for radiotherapy.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients

Johannes Gollrad, Nevenka Korpusik, Christopher Rabsahl, Dirk Boehmer, Angela Besserer, Ulrike Grittner, Alexander Boeker, Ulrich Keilholz, Antonia Joussen, Volker Budach, Ute Goerling

Summary: The decision-making process for cytogenetic testing in uveal melanoma patients is influenced by various factors, including treating physicians, internet resources, and baseline anxiety. Patients are likely to reject testing when they worry that knowing the result will have unintended consequences on their life.

SUPPORTIVE CARE IN CANCER (2022)

Article Oncology

Impact of Dose Escalation on the Efficacy of Salvage Radiotherapy for Recurrent Prostate Cancer-A Risk-Adjusted, Matched-Pair Analysis

Dirk Boehmer, Alessandra Siegmann, Sophia Scharl, Christian Ruf, Thomas Wiegel, Manuel Krafcsik, Reinhard Thamm

Summary: This study found that increasing the radiation dose during salvage radiotherapy could reduce the risk of prostate cancer relapse, suggesting that failed prostatectomy patients might benefit from dose-escalated salvage radiotherapy to improve tumor control and postpone secondary treatments. However, longer follow-ups are needed for a comprehensive recommendation.

CANCERS (2022)

Article Oncology

Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial

Anne Kluge, Stefanie Ehrbar, Melanie Grehn, Jens Fleckenstein, Wolfgang W. Baus, Frank-Andre Siebert, Achim Schweikard, Nicolaus Andratschke, Michael C. Mayinger, Judit Boda-Heggemann, Daniel Buergy, Eren Celik, David Krug, Boldizsar Kovacs, Ardan M. Saguner, Boris Rudic, Paula Bergengruen, Leif-Hendrik Boldt, Annina Stauber, Adrian Zaman, Hendrik Bonnemeier, Jurgen Dunst, Volker Budach, Oliver Blanck, Felix Mehrhof

Summary: This study aimed to provide a benchmark for treatment planning of cardiac radioablation in multicenter clinical studies and establish an objective ranking system for plan quality. By collecting and analyzing treatment plans developed using different platforms and techniques in different centers, it was found that although most plans deviated slightly from the study guidelines, the overall plan quality was acceptable. VMAT plans had steeper dose gradients in the high-dose region, while plans for robotic arm LINAC had smaller low-dose regions.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Oncology

The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial

Orit Kaidar-Person, Catherine Fortpied, Sandra Hol, Caroline Weltens, Carine Kirkove, Volker Budach, Karine Peignaux-Casasnovas, Femke van der Leij, Ernest Vonk, Mariacarla Valli, Nicola Weidner, Matthias Guckenberger, Eveline Koiter, Alain Fourquet, Harry Bartelink, Henk Struikmans, Philip Poortmans

Summary: This study analyzed the effects of different techniques of IM-MS lymph node irradiation on long-term outcomes in breast cancer patients. The results showed that using more individualized radiation therapy techniques can improve oncological outcomes without increasing the risk of late side effects.

RADIOTHERAPY AND ONCOLOGY (2022)

Review Oncology

Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases

Arndt-Christian Mueller, Daniel M. Aebersold, Clemens Albrecht, Dirk Boehmer, Michael Flentje, Ute Ganswindt, Pirus Ghadjar, Nina-Sophie Schmidt-Hegemann, Stefan Hoecht, Tobias Hoelscher, Peter Niehoff, Michael Pinkawa, Felix Sedlmayer, Frank Wolf, Constantinos Zamboglou, Daniel Zips, Thomas Wiegel

Summary: The indication for radiation therapy of the primary prostate tumor in patients with synchronous distant metastases with low metastatic burden has been revised based on randomized evidence. The STAMPEDE trial showed a survival benefit of 8% after 3 years for patients treated with standard of care and additional radiotherapy of the primary tumor. The STOPCAP meta-analysis confirmed the benefit of local radiotherapy for up to 4 bone lesions.

STRAHLENTHERAPIE UND ONKOLOGIE (2022)

Article Oncology

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT

Shivaprasad Patil, Annett Linge, Hannah Hiepe, Marianne Grosser, Fabian Lohaus, Volker Gudziol, Max Kemper, Alexander Nowak, Dominik Haim, Inge Tinhofer, Volker Budach, Maja Guberina, Martin Stuschke, Panagiotis Balermpas, Jens von Der Grun, Henning Schafer, Anca-Ligia Grosu, Amir Abdollahi, Jurgen Debus, Ute Ganswindt, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, Simon Boeke, Daniel Zips, Korinna Johrens, Gustavo B. Baretton, Michael Baumann, Mechthild Krause, Steffen Lock

Summary: This study aimed to identify high-risk head and neck squamous cell carcinoma patients who may benefit from additional concurrent chemotherapy after surgery and postoperative radiotherapy. The developed gene signature helped stratify patients into risk groups and indicated potential benefit from postoperative radiochemotherapy.

CANCERS (2022)

Article Gastroenterology & Hepatology

Total neoadjuvant therapy for locally advanced rectal cancer A meaningful treatment option?

Johannes Lauscher, Sebastian Stintzing, Dirk Boehmer

Summary: This article summarizes the current randomized trials on total neoadjuvant therapy (TNT) for locally advanced rectal cancer and discusses the indications, optimal sequence of therapy, and therapeutic regimen. The findings suggest that TNT can improve oncological outcomes in patients with lower and middle third rectal cancer and is the preferred treatment option for certain patients.

COLOPROCTOLOGY (2022)

Article Oncology

Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment-A multicenter analysis

Nikolaj Frost, Julia Roeper, Janna-Lisa Velthaus, Matthias Raspe, Elisabeth Olive, Alexander Schmittel, Bernd Schmidt, David Wasilewski, Julia Onken, Heike Lueders, Martin Witzenrath, Carolin Senger, Dirk Boehmer, Sonja Loges, Frank Griesinger, Dominik P. Modest, Christian Grohe

Summary: This study conducted a multicenter analysis on patients with oligometastatic lung cancer and found that controlling brain metastasis played a crucial role, and repeated local ablative therapy can effectively prolong the survival time.

LUNG CANCER (2022)

Meeting Abstract Oncology

The Possibility of AI-based Contours for the automatic Target Volume Determination during the Irradiation of the localized Prostate Carcinoma

V. Ehrhardt, F. Ehret, A. Kluge, D. Boehmer, V. Budach, A. Gruen

STRAHLENTHERAPIE UND ONKOLOGIE (2022)

No Data Available